DARANIDE (Taro Pharmaceuticals U.S.A., Inc.)


Welcome to the PulseAid listing for the DARANIDE drug offered from Taro Pharmaceuticals U.S.A., Inc.. This Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Sulfonamides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Taro Pharmaceuticals U.S.A., Inc.
NON-PROPRIETARY NAME: dichlorphenamide
SUBSTANCE NAME: DICHLORPHENAMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Sulfonamides [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2012-03-16
END MARKETING DATE: 0000-00-00


DARANIDE HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDARANIDE from Taro Pharmaceuticals U.S.A., Inc.
LABELER NAME: Taro Pharmaceuticals U.S.A., Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/1)
START MARKETING DATE: 2012-03-16
END MARKETING DATE: 0000-00-00
PRODUCT ID: 51672-4144_56dd77b4-82ca-4556-a3d6-fc0d1e88ca29
PRODUCT NDC: 51672-4144
APPLICATION NUMBER: NDA011366

Other DICHLORPHENAMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Strongbridge US Inc.Keveyis
Taro Pharmaceuticals U.S.A., inc.Keveyis
Taro Pharmaceuticals U.S.A., Inc.DARANIDE